Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Expert Opin Biol Ther. 2015 Dec 8;16(3):317–330. doi: 10.1517/14712598.2016.1118460

Figure 2. Current strategies applied in fabricating tissue-engineered vascular grafts.

Figure 2

ESCs: embryonic stem cells; iPSCs: induced pluripotent stem cells; PiPSCs: partially induced pluripotent stem cells; SMCs: smooth muscle cells; ECs: endothelial cells.